Baseline anti-CMV cellular immunity is similar between patients with a kidney transplant or receiving hemodialysis

Transpl Int. 2020 Aug;33(8):961-962. doi: 10.1111/tri.13620. Epub 2020 May 14.

Authors

Johan Noble¹, Louis Maniere¹, Martine Pernollet², Marie-Christine Jacob², Raphaëlle Germi^{3

4}, Eloi Chevallier¹, Lionel Rostaing^{1

4}

Affiliations

¹ Nephrology, Hemodialysis, Apheresis, and Kidney Transplantation Department, University Hospital of Grenoble-Alpes, Grenoble, France.
² Immunology Department, University Hospital of Grenoble-Alpes, Grenoble, France.
³ Virology Department, University Hospital of Grenoble-Alpes, Grenoble, France.
⁴ University Grenoble-Alpes, Grenoble, France.

PMID: 32311202
DOI: 10.1111/tri.13620

No abstract available

Publication types

Letter

MeSH terms

Antiviral Agents / therapeutic use
Cytomegalovirus
Cytomegalovirus Infections* / drug therapy
Humans
Immunity, Cellular
Kidney Transplantation*
Renal Dialysis

Substances

Antiviral Agents